Epic SciencesEpic Sciences
  • Technology
  • Products
    • DefineMBC
    • AR-V7
  • Biopharma
    Solutions
  • Publications &
    Resources
    • PUBLICATIONSNEW
    • SCIENTIFIC POSTERSNEW
    • PACKAGE INSERTSNEW
    • LIBRARYNEW
    • PODCASTS & WEBINARSNEW
  • News &
    Events
    • PRESS RELEASESNEW
    • NEWSNEW
    • EVENTSNEW
  • Company
    • EPIC STORY
    • CAREERS
    • LEADERSHIP
  • Contact
  • Sign Up
  • LATEST NEWS Epic Sciences’ DefineMBC™ Test Delivers Comprehensive Liquid Biopsy Results for Metastatic Breast Cancer Read More

PACKAGE INSERTS

AR-V7 Blood Collection Kit Package Insert (Kit FM-00049 and FM-00076)
CE Mark Blood Collection Kit Package Insert (Kit FM-000107)
CTC Liquid Biopsy Blood Collection Kit Requisition Form (LBL-00081)

Menu

  • AR-V7 Test
  • Biopharma Solutions
  • Publications
  • News Center
  • Company
  • Careers
  • Contact Us
  • Privacy Policy

9381 Judicial Drive, Suite 200
San Diego, CA 92121

858-356-6610

General Information:info@epicsciences.com

Investor Relations:ir@epicsciences.com

Media Inquiries:media@epicsciences.com

HR Inquiries:careers@epicsciences.com

©2020 Epic Sciences
v.B – LBL 00074 – 2020
‘No Cell Left Behind’ and ‘The Power of Clarity’ are registered trademarks of Epic Sciences in the United States.

Epic Sciences is licensed under the federal Clinical Laboratory Improvements Act of 1988 (CLIA), accredited by the College of American Pathologists (CAP), and is authorized to provide diagnostic services in all states including those states which require state-specific approvals including California, New York, Maryland, Pennsylvania, and Rhode Island.

  • Technology
  • Products
    • DefineMBC
    • AR-V7
  • Biopharma
    Solutions
  • Publications &
    Resources
    • PUBLICATIONSNEW
    • SCIENTIFIC POSTERSNEW
    • PACKAGE INSERTSNEW
    • LIBRARYNEW
    • PODCASTS & WEBINARSNEW
  • News &
    Events
    • PRESS RELEASESNEW
    • NEWSNEW
    • EVENTSNEW
  • Company
    • EPIC STORY
    • CAREERS
    • LEADERSHIP
  • Contact
  • Sign Up